| Charles Edward Rose Iii, | |
|
1720 Nicholasville Rd, Ste 602, Lexington, KY 40503-1404 | |
| (859) 277-4005 | |
| (859) 278-2507 |
| Full Name | Charles Edward Rose Iii |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 22 Years |
| Location | 1720 Nicholasville Rd, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568595874 | NPI | - | NPPES |
| 7100020800 | Medicaid | KY | |
| P00396857 | Other | KY | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 40916 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Lexington | Lexington, KY | Hospital |
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Saint Joseph East | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lexington Infectious Disease Consultants Psc | 5193706174 | 13 |
News Archive
A grant worth over two million pounds has been awarded to clinical researchers from the University of Liverpool and King's College London to investigate the neurological and neuropsychiatric effects of COVID-19.
Bacteria have long been thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing. But could much bigger environmental pressures be at play?
The study, published June 19 in the journal Annals of Internal Medicine, found evidence that a positive result for two standard diabetes markers in a single blood sample is a highly accurate predictor of diabetes and of major diabetes complications such as kidney disease and heart disease.
InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and six months ended June 30, 2011 and provided a business update.
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).
› Verified 1 days ago
| Entity Name | Lexington Infectious Disease Consultants Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922158294 PECOS PAC ID: 5193706174 Enrollment ID: O20040526000423 |
News Archive
A grant worth over two million pounds has been awarded to clinical researchers from the University of Liverpool and King's College London to investigate the neurological and neuropsychiatric effects of COVID-19.
Bacteria have long been thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing. But could much bigger environmental pressures be at play?
The study, published June 19 in the journal Annals of Internal Medicine, found evidence that a positive result for two standard diabetes markers in a single blood sample is a highly accurate predictor of diabetes and of major diabetes complications such as kidney disease and heart disease.
InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and six months ended June 30, 2011 and provided a business update.
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Edward Rose Iii, 1720 Nicholasville Rd, Ste 602, Lexington, KY 40503-1404 Ph: (859) 277-4005 | Charles Edward Rose Iii, 1720 Nicholasville Rd, Ste 602, Lexington, KY 40503-1404 Ph: (859) 277-4005 |
News Archive
A grant worth over two million pounds has been awarded to clinical researchers from the University of Liverpool and King's College London to investigate the neurological and neuropsychiatric effects of COVID-19.
Bacteria have long been thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing. But could much bigger environmental pressures be at play?
The study, published June 19 in the journal Annals of Internal Medicine, found evidence that a positive result for two standard diabetes markers in a single blood sample is a highly accurate predictor of diabetes and of major diabetes complications such as kidney disease and heart disease.
InVivo Therapeutics Holdings Corp., a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and six months ended June 30, 2011 and provided a business update.
Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).
› Verified 1 days ago
Mr. Fabrizio Canepa Escaro, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Infectious Disease Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |